Javascript must be enabled to continue!
Cumulative exposure to AHA Life's Essential 8 is associated with nonalcoholic fatty liver disease: a large cohort study
View through CrossRef
Abstract
Background and Aim
We aimed to explore the associations of baseline and cumulative cardiovascular health with nonalcoholic fatty liver disease (NAFLD) development and regression using the new Life’s Essential 8 score.
Methods
From a health screening database, participants who underwent at least 4 health examinations between 2012 and 2022 were recruited and categorized into two cohorts: (a) the NAFLD development cohort with no history of NAFLD prior to Exam 4 and (b) the NAFLD regression cohort with diagnosed NAFLD prior to Exam 4. The LE8 score was calculated from each component. The outcomes were defined as newly incident NAFLD or regression of existing NAFLD from Exam 4 to the end of follow-up.
Results
In the NAFLD development cohort, of 21,844 participants, 3,510 experienced incident NAFLD over a median follow-up of 2.3 years. Compared with the lowest quartile of cumulative LE8, individuals in the highest quartile conferred statistically significant 76% lower odds (hazard ratio [HR] 0.24, 95% confidence interval [CI], 0.21–0.28) of NAFLD incidence, and corresponding values for baseline LE8 were 42% (HR 0.58, 95% CI 0.53–0.65). In the NAFLD regression cohort, of 6,566 participants, 469 experienced NAFLD regression over a median follow-up of 2.4 years. Subjects with the highest quartile of cumulative LE8 had 2.03-fold (95% CI, 1.51–2.74) higher odds of NAFLD regression, and corresponding values for baseline LE8 were 1.61-fold (95% CI, 1.24–2.10).
Conclusion
Cumulative ideal cardiovascular health exposure is associated with reduced NAFLD development and increased NAFLD regression. Improving and preserving health behaviors and factors should be emphasized as an important part of NAFLD prevention and intervention strategies.
Graphical Abstract
Springer Science and Business Media LLC
Title: Cumulative exposure to AHA Life's Essential 8 is associated with nonalcoholic fatty liver disease: a large cohort study
Description:
Abstract
Background and Aim
We aimed to explore the associations of baseline and cumulative cardiovascular health with nonalcoholic fatty liver disease (NAFLD) development and regression using the new Life’s Essential 8 score.
Methods
From a health screening database, participants who underwent at least 4 health examinations between 2012 and 2022 were recruited and categorized into two cohorts: (a) the NAFLD development cohort with no history of NAFLD prior to Exam 4 and (b) the NAFLD regression cohort with diagnosed NAFLD prior to Exam 4.
The LE8 score was calculated from each component.
The outcomes were defined as newly incident NAFLD or regression of existing NAFLD from Exam 4 to the end of follow-up.
Results
In the NAFLD development cohort, of 21,844 participants, 3,510 experienced incident NAFLD over a median follow-up of 2.
3 years.
Compared with the lowest quartile of cumulative LE8, individuals in the highest quartile conferred statistically significant 76% lower odds (hazard ratio [HR] 0.
24, 95% confidence interval [CI], 0.
21–0.
28) of NAFLD incidence, and corresponding values for baseline LE8 were 42% (HR 0.
58, 95% CI 0.
53–0.
65).
In the NAFLD regression cohort, of 6,566 participants, 469 experienced NAFLD regression over a median follow-up of 2.
4 years.
Subjects with the highest quartile of cumulative LE8 had 2.
03-fold (95% CI, 1.
51–2.
74) higher odds of NAFLD regression, and corresponding values for baseline LE8 were 1.
61-fold (95% CI, 1.
24–2.
10).
Conclusion
Cumulative ideal cardiovascular health exposure is associated with reduced NAFLD development and increased NAFLD regression.
Improving and preserving health behaviors and factors should be emphasized as an important part of NAFLD prevention and intervention strategies.
Graphical Abstract.
Related Results
Grading of Fatty Liver Disease in Non-Obese Elderly Patients On Ultrasound
Grading of Fatty Liver Disease in Non-Obese Elderly Patients On Ultrasound
Background and Introduction: Non-alcoholic fatty liver disease (NAFLD) has been demonstrated that insulin resistance and metabolic syndrome are associated with non-alcoholic fatty ...
Identification of Heat shock protein family A member 5 (HSPA5) targets involved in nonalcoholic fatty liver disease
Identification of Heat shock protein family A member 5 (HSPA5) targets involved in nonalcoholic fatty liver disease
Abstract
Background
HSPA5 is an endoplasmic reticulum chaperone which regulates cell metabolism, especially lipid metabolism. There are many reports about the role of HSPA...
Cases of acquired hemophilia A following COVID‐19 vaccines: Cogent safety signal or possible reporting/detection bias? Preliminary evidence from Tuscany, Italy
Cases of acquired hemophilia A following COVID‐19 vaccines: Cogent safety signal or possible reporting/detection bias? Preliminary evidence from Tuscany, Italy
AbstractPurposeSeveral case reports of acquired hemophilia A (AHA) following COVID‐19 vaccines were recently published. A possible increased incidence of AHA during the COVID‐19 va...
The Value of Quantitative Ultrasound Elastography in the Assessment of Non-Alcoholic Fatty Liver Disease in Children
The Value of Quantitative Ultrasound Elastography in the Assessment of Non-Alcoholic Fatty Liver Disease in Children
Objective:
This preliminary investigation aimed to assess the value of two elastography techniques, sound touch elastography (STE) and sound touch
quantification (STQ), in measurin...
Effect and Safety of Pioglitazone-Metformin Tablets in the Treatment of Newly Diagnosed Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease in Shaanxi Province: A Randomized, Double-Blinded, Double-Simulated Multicenter Study
Effect and Safety of Pioglitazone-Metformin Tablets in the Treatment of Newly Diagnosed Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease in Shaanxi Province: A Randomized, Double-Blinded, Double-Simulated Multicenter Study
Objective. The aim of study was to evaluate the effect and safety of pioglitazone-metformin combined treatment in the newly diagnosed type 2 diabetes patients with nonalcoholic fat...
АНТИОКСИДАНТЫ КАК ПОТЕНЦИАЛЬНЫЕ БИОМАРКЕРЫ СТАДИЙ НЕАЛКОГОЛЬНОЙ ЖИРОВОЙ БОЛЕЗНИ ПЕЧЕНИ
АНТИОКСИДАНТЫ КАК ПОТЕНЦИАЛЬНЫЕ БИОМАРКЕРЫ СТАДИЙ НЕАЛКОГОЛЬНОЙ ЖИРОВОЙ БОЛЕЗНИ ПЕЧЕНИ
Nonalcoholic fatty liver disease is a complex and multifactorial pathology associated with multiple epigenetic, genetic and environmental factors, and its pathogenesis is still not...
Fatty liver formation in fulminant type 1 diabetes
Fatty liver formation in fulminant type 1 diabetes
SummaryA 32-year-old woman presented with 3days of epigastric pain and was admitted to our hospital (day 3 of disease). We diagnosed acute pancreatitis based on epigastric abdomina...
Association of nonalcoholic fatty liver disease with uric acid, BMI and dyslipidemia.
Association of nonalcoholic fatty liver disease with uric acid, BMI and dyslipidemia.
Abstract:
Introduction: Nonalcoholic fatty liver disease (NAFLD) is gradually recognized as a main health challenge especially in the developed countries. NAFLD comprises of ...

